Security key
49372L100
Kezar Life Sciences, Inc. - Common Stock, par value $0.001 per share (KZR)
CUSIP: 49372L100
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 37,449,865
- Total 13F value
- $28,947,595
- Share change
- +585,452
- Put/Call ratio
- 4.4%
- SEC-reported price per share
- $0.77
- Number of holders
- 54
- Value change
- +$900,937
- Number of buys
- 17
- Number of sells
- 44
- Shares outstanding
- 7,393,623
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
54
Top holders
10
KZR full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Kezar Life Sciences, Inc. SEC filings
Kezar Life Sciences, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 49372L100
Recent filing periods:
Ownership snapshot
Top reported holders of KZR - Kezar Life Sciences, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
SUVRETTA CAPITAL MANAGEME...
Disclosed value leader
SUVRETTA CAPITAL MANAGEME...
Comparable rows
15/15
Latest evidence
30 Jun 2024
13F
Lead comparable stake: 97%
Showing 1-6 of 15 holder rows.
Quick read
SUVRETTA CAPITAL MANAGEMENT, LLC leads the comparable SEC ownership view at 97%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens SUVRETTA CAPITAL MANAGEMENT, LLC's linked filing trail.
Comparable ownership
Top 5
SUVRETTA CAPITAL MANAGEMENT, LLC
97%
Avidity Partners Management LP
68%
VANGUARD GROUP INC
37%
SPHERA FUNDS MANAGEMENT LTD.
28%
ORBIMED ADVISORS LLC
26%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
Company
|
97%
|
$4,300,555
7,167,591 shares
|
— | 30 Jun 2024 |
| Avidity Partners Management LP |
13F
Company
|
68%
|
$3,015,600
5,026,000 shares
|
— | 30 Jun 2024 |
| VANGUARD GROUP INC |
13F
Company
|
37%
|
$1,644,663
2,741,105 shares
|
— | 30 Jun 2024 |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
Company
|
28%
|
$1,231,006
2,051,676 shares
|
— | 30 Jun 2024 |
| ORBIMED ADVISORS LLC |
13F
Company
|
26%
|
$1,156,200
1,927,000 shares
|
— | 30 Jun 2024 |
| ACADIAN ASSET MANAGEMENT LLC |
13F
Company
|
25%
|
$1,112,000
1,855,194 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
54
Shares
37,449,865
Rows available
54
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q3 2025 Across Filers
Q3 2025 holders
1
Q3 2024 holders
54
Holder diff
53
| Investor | Q3 2025 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q3 2025 value | Q3 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend